Evidence map›Paper›PMID 31141399›Full record

ArticleAmerican journal of physiology. Renal physiology2019

Detrusor contractility to parasympathetic mediators is differentially altered in the compensated and decompensated states of diabetic bladder dysfunction.

Nicole S Klee, Robert S Moreland, Derek M Kendig

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. IR-61 Improves Voiding FunctionFrontiers in pharmacology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicole S KleeDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Robert S MorelandDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania.
Derek M KendigDepartment of Biology, Loyola University Maryland, Baltimore, Maryland.
Drexel University · USLoyola University Maryland · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic bladder dysfunction (DBD) affects up to 50% of all patients with diabetes, characterized by symptoms of both overactive and underactive bladder. Although most diabetic bladder dysfunction studies have been performed using models with type 1 diabetes, few have been performed in models of type 2 diabetes, which accounts for ~90% of all diabetic cases. In a type 2 rat model using a high-fat diet (HFD) and two low doses of streptozotocin (STZ), we examined voiding measurements and functional experiments in urothelium-denuded bladder strips to establish a timeline of disease progression. We hypothesized that overactive bladder symptoms (compensated state) would develop and progress into symptoms characterized by underactive bladder (decompensated state). Our results indicated that this model developed the compensated state at 1 wk after STZ and the decompensated state at 4 mo after STZ administration. Diabetic bladders were hypertrophied compared with control bladders. Increased volume per void and detrusor muscle contractility to exogenous addition of carbachol and ATP confirmed the development of the compensated state. This enhanced contractility to carbachol was not due to increased levels of M

Indexed as

Muscle ContractionUrodynamicsAdenosine TriphosphateAnimalsCarbacholCholinergic AgonistsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Diet, High-FatDisease ProgressionMaleMuscle StrengthParasympathetic Nervous SystemRats, Sprague-DawleyStreptozocinTime FactorsAdenosine TriphosphateCarbacholCholinergic AgonistsStreptozocindiabetesdiabetic cystopathylower urinary tractsmooth muscle

Identifiers

PMID31141399
PMCPMC6732447
OpenAlexW2947216752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.